Validity, reliability and responsiveness of digital visual analogue scales for chronic spontaneous urticaria monitoring: A CRUSE® mobile health study
Issued Date
2024-01-01
Resource Type
ISSN
01054538
eISSN
13989995
Scopus ID
2-s2.0-85207494050
Pubmed ID
39445583
Journal Title
Allergy: European Journal of Allergy and Clinical Immunology
Rights Holder(s)
SCOPUS
Bibliographic Citation
Allergy: European Journal of Allergy and Clinical Immunology (2024)
Suggested Citation
Sousa-Pinto B., Ramanauskaite A., Neisinger S., Witte-Händel E., Gimenez-Arnau A.M., Guillet C., Parisi C.A.S., Katelaris C.H., Fomina D., Larenas-Linnemann D., García E., Kocatürk E., Siebenhaar F., Lima H., Kaidashev I., Nasr I., Canales I.O., Ojeda I.C., Hébert J., Bousquet J., Bernstein J.A., Peter J., Sanchez J., Sousa J.I.L., Kulthanan K., Weller K., Godse K., Rutkowski K., Lapina L., Bouillet L., Han L.L., Ensina L.F., Gonçalo M., Magerl M., van Doorn M., Metz M., Khoshkhui M., Hide M., Türk M., Kurjāne N., Conlon N., Salameh P., Kolkhir P., Asero R., Stepanenko R., Altrichter S., Gil-Mata S., Thomsen S.F., Zuberbier T., Tsaryk V., Ye Y.M., Brzoza Z., Zhao Z., Maurer M. Validity, reliability and responsiveness of digital visual analogue scales for chronic spontaneous urticaria monitoring: A CRUSE® mobile health study. Allergy: European Journal of Allergy and Clinical Immunology (2024). doi:10.1111/all.16371 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/101868
Title
Validity, reliability and responsiveness of digital visual analogue scales for chronic spontaneous urticaria monitoring: A CRUSE® mobile health study
Author(s)
Sousa-Pinto B.
Ramanauskaite A.
Neisinger S.
Witte-Händel E.
Gimenez-Arnau A.M.
Guillet C.
Parisi C.A.S.
Katelaris C.H.
Fomina D.
Larenas-Linnemann D.
García E.
Kocatürk E.
Siebenhaar F.
Lima H.
Kaidashev I.
Nasr I.
Canales I.O.
Ojeda I.C.
Hébert J.
Bousquet J.
Bernstein J.A.
Peter J.
Sanchez J.
Sousa J.I.L.
Kulthanan K.
Weller K.
Godse K.
Rutkowski K.
Lapina L.
Bouillet L.
Han L.L.
Ensina L.F.
Gonçalo M.
Magerl M.
van Doorn M.
Metz M.
Khoshkhui M.
Hide M.
Türk M.
Kurjāne N.
Conlon N.
Salameh P.
Kolkhir P.
Asero R.
Stepanenko R.
Altrichter S.
Gil-Mata S.
Thomsen S.F.
Zuberbier T.
Tsaryk V.
Ye Y.M.
Brzoza Z.
Zhao Z.
Maurer M.
Ramanauskaite A.
Neisinger S.
Witte-Händel E.
Gimenez-Arnau A.M.
Guillet C.
Parisi C.A.S.
Katelaris C.H.
Fomina D.
Larenas-Linnemann D.
García E.
Kocatürk E.
Siebenhaar F.
Lima H.
Kaidashev I.
Nasr I.
Canales I.O.
Ojeda I.C.
Hébert J.
Bousquet J.
Bernstein J.A.
Peter J.
Sanchez J.
Sousa J.I.L.
Kulthanan K.
Weller K.
Godse K.
Rutkowski K.
Lapina L.
Bouillet L.
Han L.L.
Ensina L.F.
Gonçalo M.
Magerl M.
van Doorn M.
Metz M.
Khoshkhui M.
Hide M.
Türk M.
Kurjāne N.
Conlon N.
Salameh P.
Kolkhir P.
Asero R.
Stepanenko R.
Altrichter S.
Gil-Mata S.
Thomsen S.F.
Zuberbier T.
Tsaryk V.
Ye Y.M.
Brzoza Z.
Zhao Z.
Maurer M.
Author's Affiliation
Institut National de Santé Publique, d’Épidémiologie Clinique et de Toxicologie-Liban
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP
Siriraj Hospital
Gilbert and Rose-Marie Chagoury School of Medicine
University of Nicosia Medical School
Kepler Universitätsklinikum
Peking University First Hospital
Clínica San Felipe
Moscow Healthcare Department
Astana Medical University
Hospital Regional Rancagua
Universidad Espíritu Santo
Paula Stradina Clinical University Hospital
University of Cape Town Lung Institute
CHU de Québec-Université Laval
School of Life Sciences Fudan University
Royal Hospital
Poltava State Medical University
Riga Stradins University
Universidad de Antioquia
Universidad de Los Andes, Colombia
Universidade de Coimbra, Faculdade de Medicina
Universitat Pompeu Fabra Barcelona
Erasmus MC
McMaster University
Hiroshima University
Erciyes University, Faculty of Medicine
Pontificia Universidad Católica de Chile
Ajou University School of Medicine
Charité – Universitätsmedizin Berlin
Bispebjerg Hospital
Johannes Kepler University Linz
Western Sydney University
University of Cincinnati College of Medicine
Faculdade de Medicina da Universidade do Porto (FMUP)
Universidade Federal de São Paulo
Sechenov First Moscow State Medical University
Hospital Italiano de Buenos Aires
Universitätsspital Zürich, Dermatologische Klinik
Universidade do Porto
Koç Üniversitesi
Centre Hospitalier Universitaire de Grenoble
Guy's and St Thomas' NHS Foundation Trust
Bogomolets National Medical University
Uniwersytet Opolski
Dr. D.Y. Patil Medical College, Navi Mumbai
Groote Schuur Hospital
St James's Hospital
Mashhad University of Medical Sciences
University Dermatological Center (DermaCDU)
Center of Excellence in Asthma and Allergy Larenas Hospital Médica Sur
Clinica San Carlo
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP
Siriraj Hospital
Gilbert and Rose-Marie Chagoury School of Medicine
University of Nicosia Medical School
Kepler Universitätsklinikum
Peking University First Hospital
Clínica San Felipe
Moscow Healthcare Department
Astana Medical University
Hospital Regional Rancagua
Universidad Espíritu Santo
Paula Stradina Clinical University Hospital
University of Cape Town Lung Institute
CHU de Québec-Université Laval
School of Life Sciences Fudan University
Royal Hospital
Poltava State Medical University
Riga Stradins University
Universidad de Antioquia
Universidad de Los Andes, Colombia
Universidade de Coimbra, Faculdade de Medicina
Universitat Pompeu Fabra Barcelona
Erasmus MC
McMaster University
Hiroshima University
Erciyes University, Faculty of Medicine
Pontificia Universidad Católica de Chile
Ajou University School of Medicine
Charité – Universitätsmedizin Berlin
Bispebjerg Hospital
Johannes Kepler University Linz
Western Sydney University
University of Cincinnati College of Medicine
Faculdade de Medicina da Universidade do Porto (FMUP)
Universidade Federal de São Paulo
Sechenov First Moscow State Medical University
Hospital Italiano de Buenos Aires
Universitätsspital Zürich, Dermatologische Klinik
Universidade do Porto
Koç Üniversitesi
Centre Hospitalier Universitaire de Grenoble
Guy's and St Thomas' NHS Foundation Trust
Bogomolets National Medical University
Uniwersytet Opolski
Dr. D.Y. Patil Medical College, Navi Mumbai
Groote Schuur Hospital
St James's Hospital
Mashhad University of Medical Sciences
University Dermatological Center (DermaCDU)
Center of Excellence in Asthma and Allergy Larenas Hospital Médica Sur
Clinica San Carlo
Corresponding Author(s)
Other Contributor(s)
Abstract
Background: CRUSE® is an app that allows patients with chronic spontaneous urticaria (CSU) to monitor their daily disease activity through the use of visual analogue scales (VASs). We aimed to determine the concurrent validity, reliability, responsiveness and minimal important difference (MID) of CRUSE® VASs. Methods: We evaluated the properties of three daily VASs: VAS for how much patients were affected by their CSU (‘VAS urticaria’), VAS for the impact of urticaria on work/school productivity (‘VAS productivity’) and the VAS of EQ-5D. Concurrent validity was assessed by measuring the association between each VAS and the Urticaria Activity Score (UAS). Intra-rater reliability was determined based on the data of users providing multiple daily questionnaires within the same day. Test–retest reliability and responsiveness (ability to change), respectively, were tested in clinically stable and clinically unstable users. MIDs were determined using distribution-based methods. Results: We included 5938 patients (67,380 days). Concurrent validity was high, with VAS urticaria being more strongly associated with the UAS score than the remaining VASs. Intra-rater reliability was also high, with intraclass correlation coefficients (ICC) being above 0.950 for all VASs. Moderate-high test–retest reliability and responsiveness were observed, with reliability ICC being highest for VAS EQ-5D and responsiveness being highest for VAS urticaria. The MID for VAS urticaria was 17 (out of 100) units, compared to 15 units for VAS productivity and 11 units for VAS EQ-5D. Conclusion: Daily VASs for CSU available in the CRUSE® app display high concurrent validity and intra-rater reliability and moderate-high test–retest reliability and responsiveness.